IRX3 | Iroquois homeobox 3 | Transcription factors
| | | | | Tissue enhanced |
IRX4 | Iroquois homeobox 4 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
IRX5 | Iroquois homeobox 5 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
IVL | Involucrin | Plasma proteins
| | | | | Tissue enhanced |
JAG2 | Jagged 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
KLF8 | Kruppel-like factor 8 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
KLK11 | Kallikrein-related peptidase 11 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KRT73 | Keratin 73 | Plasma proteins
| | | | | Tissue enhanced |
KRT80 | Keratin 80 | Plasma proteins
| | | | | Tissue enhanced |
KRT9 | Keratin 9 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
KY | Kyphoscoliosis peptidase | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
LAD1 | Ladinin 1 | Plasma proteins
| | | | | Tissue enhanced |
LRIT2 | Leucine-rich repeat, immunoglobulin-like and transmembrane domains 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
LRLE1 | Liver-related low express protein 1; Uncharacterized protein | | | | | | Tissue enhanced |
LRP4 | Low density lipoprotein receptor-related protein 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRRC16B | Leucine rich repeat containing 16B | | | | | | Tissue enhanced |
LTB4R | Leukotriene B4 receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
LTB4R2 | Leukotriene B4 receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
LYPD5 | LY6/PLAUR domain containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
MAB21L3 | Mab-21-like 3 (C. elegans) | | | | | | Tissue enhanced |
MATN4 | Matrilin 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MEGF6 | Multiple EGF-like-domains 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
MICALCL | MICAL C-terminal like | Cancer-related genes
| | | | | Tissue enhanced |
MMP27 | Matrix metallopeptidase 27 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MST1R | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MT4 | Metallothionein 4 | | | | | | Tissue enhanced |
NDUFA4L2 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 | Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NHLH2 | Nescient helix loop helix 2 | Transcription factors
| | | | | Tissue enhanced |
NIPAL4 | NIPA-like domain containing 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
NMU | Neuromedin U | Predicted secreted proteins
| | | | | Tissue enhanced |
NPAS1 | Neuronal PAS domain protein 1 | Transcription factors
| | | | | Tissue enhanced |
NSG1 | Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. | Predicted membrane proteins
| | | | | Tissue enhanced |
NTF4 | Neurotrophin 4 | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
NXPH4 | Neurexophilin 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
OCA2 | Oculocutaneous albinism II | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
OLFM2 | Olfactomedin 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OTX1 | Orthodenticle homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
PAPL | Iron/zinc purple acid phosphatase-like protein | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PARD6G | Par-6 family cell polarity regulator gamma | | | | | | Tissue enhanced |
PAX3 | Paired box 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
PERP | PERP, TP53 apoptosis effector | Predicted membrane proteins
| | | | | Tissue enhanced |
PGLYRP4 | Peptidoglycan recognition protein 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
PHYHIP | Phytanoyl-CoA 2-hydroxylase interacting protein | | | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
PLCH2 | Phospholipase C, eta 2 | Enzymes
| | | | | Tissue enhanced |
PLEKHG5 | Pleckstrin homology domain containing, family G (with RhoGef domain) member 5 | Disease related genes
| | | | | Tissue enhanced |
POF1B | Premature ovarian failure, 1B | Disease related genes
| | | | | Tissue enhanced |
POSTN | Periostin, osteoblast specific factor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PPFIA3 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | | | | | | Tissue enhanced |